These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 33580908)

  • 1. Epidemiological survey of the psoriasis patients in the Japanese Society for Psoriasis Research from 2013 to 2018.
    Kamiya K; Oiso N; Kawada A; Ohtsuki M
    J Dermatol; 2021 Jun; 48(6):864-875. PubMed ID: 33580908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological survey of patients with psoriatic arthritis in the Japanese Society for Psoriasis Research from 2017 to 2020.
    Kamiya K; Ohtsuki M
    J Dermatol; 2023 Jan; 50(1):12-25. PubMed ID: 36261862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological survey of patients with pustular psoriasis in the Japanese Society for Psoriasis Research from 2017 to 2020.
    Kamiya K; Ohtsuki M
    J Dermatol; 2023 Jan; 50(1):3-11. PubMed ID: 36152301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese guidance for use of biologics for psoriasis (the 2019 version).
    Saeki H; Terui T; Morita A; Sano S; Imafuku S; Asahina A; Komine M; Etoh T; Igarashi A; Torii H; Abe M; Nakagawa H; Watanabe A; Yotsuyanagi H; Ohtsuki M;
    J Dermatol; 2020 Mar; 47(3):201-222. PubMed ID: 31916326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological survey from 2009 to 2012 of psoriatic patients in Japanese Society for Psoriasis Research.
    Ito T; Takahashi H; Kawada A; Iizuka H; Nakagawa H;
    J Dermatol; 2018 Mar; 45(3):293-301. PubMed ID: 29115687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug survival of biologic agents for psoriatic patients in a real-world setting in Japan.
    Kishimoto M; Komine M; Kamiya K; Sugai J; Mieno M; Ohtsuki M
    J Dermatol; 2020 Jan; 47(1):33-40. PubMed ID: 31696543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective observational study on biological drug treatment in a daily practice serving patients with psoriasis in Japan.
    Ohata C; Ohyama B; Nanri A; Shintani T; Nakama T
    J Dermatolog Treat; 2019 Feb; 30(1):45-48. PubMed ID: 29676591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review.
    Sanchez IM; Sorenson E; Levin E; Liao W
    Dermatol Ther (Heidelb); 2017 Dec; 7(4):425-446. PubMed ID: 29143230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis.
    Tada Y; Watanabe R; Noma H; Kanai Y; Nomura T; Kaneko K
    J Dermatol Sci; 2020 Jul; 99(1):53-61. PubMed ID: 32600737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).
    Saeki H; Mabuchi T; Asahina A; Abe M; Igarashi A; Imafuku S; Okubo Y; Komine M; Sano S; Torii H; Morita A; Yotsuyanagi H; Watanabe A; Ohtsuki M;
    J Dermatol; 2023 Feb; 50(2):e41-e68. PubMed ID: 36582113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis.
    Loos AM; Liu S; Segel C; Ollendorf DA; Pearson SD; Linder JA
    J Am Acad Dermatol; 2018 Jul; 79(1):135-144.e7. PubMed ID: 29438757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan.
    Igarashi A; Kuwabara H; Fahrbach K; Schenkel B
    J Dermatolog Treat; 2013 Oct; 24(5):351-5. PubMed ID: 22632451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of erythrodermic psoriasis with biologics: A systematic review.
    Carrasquillo OY; Pabón-Cartagena G; Falto-Aizpurua LA; Santiago-Vázquez M; Cancel-Artau KJ; Arias-Berrios G; Martín-García RF
    J Am Acad Dermatol; 2020 Jul; 83(1):151-158. PubMed ID: 32247872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of interstitial lung disease during biological treatment in Japanese patients with psoriasis.
    Matsumoto Y; Abe N; Tobita R; Kawakami H; Nakayama H; Setoguchi Y; Tsuboi R; Okubo Y
    Clin Exp Dermatol; 2020 Oct; 45(7):853-858. PubMed ID: 32356612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brodalumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal.
    Wade R; Grosso A; South E; Rothery C; Saramago P; Schmitt L; Wright K; Palmer S
    Pharmacoeconomics; 2019 Feb; 37(2):131-139. PubMed ID: 30112635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations.
    Nast A; Smith C; Spuls PI; Avila Valle G; Bata-Csörgö Z; Boonen H; De Jong E; Garcia-Doval I; Gisondi P; Kaur-Knudsen D; Mahil S; Mälkönen T; Maul JT; Mburu S; Mrowietz U; Reich K; Remenyik E; Rønholt KM; Sator PG; Schmitt-Egenolf M; Sikora M; Strömer K; Sundnes O; Trigos D; Van Der Kraaij G; Yawalkar N; Dressler C
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2461-2498. PubMed ID: 33349983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Ramaekers BLT; Wolff RF; Pouwels X; Oosterhoff M; Van Giessen A; Worthy G; Noake C; Armstrong N; Kleijnen J; Joore MA
    Pharmacoeconomics; 2018 Aug; 36(8):917-927. PubMed ID: 29480455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Number needed to treat and costs per responder among biologic treatments for moderate-to-severe plaque psoriasis in Japan.
    Imafuku S; Nakano A; Dakeshita H; Li J; Betts KA; Guerin A
    J Dermatolog Treat; 2018 Feb; 29(1):24-31. PubMed ID: 28608740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis: a Japanese perspective.
    Igarashi A; Igarashi A; Graham CN; Gilloteau I; Tani Y
    J Med Econ; 2018 Oct; ():1-9. PubMed ID: 30289010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.